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Abstract.  Analyses were made of the fibrinolytic, 
plasminogen-activating  system in skeletal muscle to de- 
termine if a regulating  influence of the nerve could be 
detected on these enzymes. Young male mice under- 
went right  sciatic neurectomy. Extracts were prepared 
from denervated muscle at 2-17 d after axotomy and 
compared with controls.  Using a cascade-style bio- 
chemical assay (R~nby,  M., B.  Nortman, and 
E  Wall6n,  1982,  Thromb. Res., 27:743-748)  we found 
that low levels of plasminogen activator (PA) were 
present in adult,  innervated mouse muscle, but that 
denervation resulted in a marked time-dependent in- 
crease in enzyme activity. Qualitative separation 
showed an eightfold increase in urokinase-like PA with 
moderate elevation of tissue PA activity after  10 d.  Fi- 
brin zymography (Granelli-Piperno,  A.,  and E.  Reich, 
1978, J.  Exp.  Med.,  148:223-234) revealed clear zones 
of lysis corresponding to molecular masses of 48 kD 
for urokinase-like PA and 75 kD for tissue PA, consis- 
tent with the molecular masses found for these en- 
zymes in other tissues of the mouse (Dane,  K.,  P. A. 
Andreasen,  J.  GrCndahl-Hansen,  P. Kristensen,  L.  S. 
Nielsen, and L.  Skriver,  1985, Adv. Cancer Res., 
44:139-266). 
In other studies we have shown that PA-activated 
plasmin readily attacks critical adhesive basement 
membrane molecules. The present results indicate that 
enzymes involved in plasminogen activation, particu- 
larly urokinase-like PA,  rapidly increase after ax- 
otomy, suggesting they may have a role early in mus- 
cle denervation.  Similar alterations in PA activity 
might underlie the elimination of polyneuronal inner- 
vation during  mammalian  muscle development.  Cer- 
tain neuromuscular diseases may also involve activa- 
tion of these enzymes, resulting  in degradation of 
basement membrane zone components and,  therefore, 
warrant further study. 
TER injury, skeletal muscle undergoes a form of tissue 
remodeling that can result in relatively complete re- 
generation  (1, 5, 6, 39, 40). Although the molecular 
mechanisms underlying  this remodeling are not understood, 
the cellular basis appears to reside within the muscle tissue 
itself. For example, after mincing of mammalian  muscle and 
replacing the minced tissue in the vacated site of the removed 
muscle (see reference 4) rather remarkable regeneration  of 
form and function takes place.  X-irradiation  of the minced 
tissue  before  replacing  completely  blocks  this  muscle 
regeneration  (20).  This type of experiment eliminates  the 
contribution of invading cells from the vascular system in the 
regeneration  process  (20).  Experiments  such  as  this  and 
others (44, 51, 52) support the hypothesis  that  muscle re- 
generates from activation of quiescent "satellite" cells present 
within mammalian  skeletal muscle (38).  The mechanism(s) 
for activating  these stem or satellite cells is unknown. 
After experimental  denervation  of mammalian  muscle a 
number of changes also occur. These include gross atrophy, 
nuclear  alterations,  and  cellular proliferation,  as  well  as 
metabolic and physiologic alterations (see references 27, 59). 
Early changes are located at the cell surface and include the 
loss  of end  plate-specific  A12  (16  S)  acetylcholinesterase 
(12-14, 16), reduction in fibronectin (16), and invasion of the 
end plate by Schwarm cells (42). These changes occur within 
1-3 d of severing the nerve, in advance of decrease in muscle 
bulk and reduction in muscle-specific sarcoplasmic proteins 
(27, 59). Reduction in the latter has been suggested to result 
from  degradation  by  Ca÷+-activated  (10), lysosomal  (45, 
48), or, possibly,  membrane-bound neutral  proteases (54). 
While conclusive data indicating increased synthesis and re- 
lease of neutral  proteases early in denervation  are lacking, 
previous studies have suggested a role for such enzymes in 
reduction  and  release of A12 acetylcholinesterase (13, 14) 
and sarcolemmal  fibronectin  (16) and in the internalization 
and partial  degradation  of acetylcholine receptors (29, 43, 
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nervation of denervated muscle fibers as well as for the acti- 
vation of satellite cells (38).  Thus, changes attendant upon 
denervation result in a specialized form of remodeling in the 
neuromuscular system. Since tissue remodeling in other sys- 
tems has been associated with increased activity of serine 
proteases  such  as  plasminogen  activator (PA) t  (see  refer- 
ence 9), we were interested in studying PA in skeletal muscle 
after denervation. Previous studies indicated that PA was the 
predominant  neutral  protease  secreted  by cultured  clonal 
murine skeletal muscle cells  (18). We now present results 
demonstrating that low levels of PA are present in adult, in- 
nervated  mouse  muscle  but  that  denervation  results  in  a 
marked time-dependent increase in urokinase-like PA (uPA) 
with  subsequent elevation of tissue PA  (tPA).  The muscle 
uPA after denervation has a molecular mass of 48 kD similar 
to uPA from other mouse tissues (7). In this paper we also 
report that plasminogen-dependent fibrinolytic activity was 
localized over denervated muscle fibers, mononuclear cells, 
and blood vessels. The latter may be the source of the tPA 
(molecular mass of 75 kD) that is found late in the denerva- 
tion time course. 2 
Materials and Methods 
Materials 
Lys-plasminogen, a  modified form of native glu-plasminogen with NH2- 
terminal  lysine  (Mr  85,000)  was  purchased  from  Choay  Laboratories 
(Paris, France). The small quantity of plasmin present in the reagent was 
eliminated by prior chromatography on aprotinin agarose, Glu-plasminogen 
was kindly donated by Dr. O. Bertrand (HSpilil Beaujon, Clichy, France). 
tPA, isolated from human melanoma cells in tissue culture, was a generous 
gift of Drs. Lijnen and Collen (University of Leuven, Leuven, Belgium). 
The specific activity, expressed in uPA equivalent units, was 90,000 IU/mg. 
Chromogenic plasmin-specific S-2251  substrate was purchased from Kabi 
(AB) (Stockholm, Sweden). Ketamine (Kelilar) was from parke, Davis & 
Co. (Chicago, IL) and acepromazine (Vetranquil)  from Clin-Midy (Paris, 
France). Plasminogen-free human or bovine fibrinogen was purchased from 
Kabi (AB) and bovine thrombin from parke, Davis & Co. Fibrin monomer 
(FM) was prepared by clotting human fibrinogen (1%) in distilled water with 
reptilase (Stago, Asni~res, France). The clot was squeezed out, washed in 
0.15 M  NaCI, and dissolved in 5 M urea. 
Denervation and Preparation of  Extracts 
4-6-wk-old male C57/BL mice (Iffa-Credo, l~rbresle, France) were anes- 
thetized with intraperitoneal ketamine (10 mg/ml) and acepromazine, 9:1 
(vol/vol), 10 ~l/g. Then mid-peim (sciatic notch) axotomy, with removal of 
a 5-mm segment of sciatic nerve, was performed. At varying times there- 
after, after cervical dislocation, denervated and contralateral (unoperated) 
control hind-limb, sciatic-innervated muscles were cleaned of blood vessels 
and connective tissue and homogenized in 100 mM Tris-CI, 2 mM EDTA, 
pH 7.6 (1:10, wt/vol) with a Polytron (Brinkmann Instruments Co., Switzer- 
land) tissue homogenizer, all at 4°C.  Homogenates were centrifuged at 
12,000 g for 30 min (Sorvall Instruments Div., Wilmington, DE). The su- 
pernatant was further centrifuged at  100,000 g  for 1 h  (Beckman Instru- 
ments, Inc., palo Alto, CA). After all procedures, fractions were aliquoted, 
flash-frozen in liquid N2, and stored at  -80°C umil used. 
Amidolytic Assay of  PA Activity in Muscle 
Activation of  plasminogen to plasmin was followed by determination of  plas- 
rain activity on the synthetic substrate S-2251  (49). To 0.1 ml (85 ~tg/ml) 
of lys-plasminogen in assay buffer (0.1 M sodium phosphate, pH 7.3; con- 
taining l0 mM EDTA, 0.01% NaNs, and 0.01% Triton X-100) were added 
1. Abbreviations used in this paper: FM, fibrin monomer; PA, plasminogen 
activator; tPA, tissue PA; uPA, urokinase-like PA. 
2. Presented in part at the International Symposium on Molecular Aspects 
of Neurobiology, Florence, Italy,  June 19-21, 1985. 
either 0.1 ml of muscle extract at different dilutions or 0.1 ml of purified 
tPA or uPA diluted in assay buffer containing 0.01% Tween 80 (Sigma Chem- 
ical Co., St. Louis, MO) to avoid nonspecific adsorption. After this, either 
10 p.l of  FM (2,5 mg/ml) or 10 I.tl assay buffer were added followed by 0.1 ml 
S-2251 (3 mM) in distilled water. Incubation was performed at 37°C in flat- 
bottomed microtiter plates (Dynatech Laboratories, Inc., Alexandria, VA). 
The release of paranitroaniline from S-2251  was determined in each well 
by measuring the absorbance at 405 nm using a micro-ELISA autoreader 
(Dynatech Laboratories, Inc.). Color development was linear for 6 h after 
a 2-h lag, or if  expressed to the fourth power (60). Controls, including buffer 
alone and extracts without plasminogen, were performed in parallel wells. 
Generally, 2 or 3 replicate wells were included in each assay. Our current 
results are expressed in absorbance units after 4  h incubation at 37°C. 
Fibrin Zymography 
SDS PAGE was performed according to Laemmli (34) in 10% gels and was 
followed by fibrin-plate zymography according to the method of Granelli- 
Piperno and Reich (21). After SDS PAGE and elimination of SDS in 2.5% 
Triton X-100, the acrylamide gels were transferred onto pre-cast fibrin plates 
and incubated in a moist atmosphere at 37°C for 24 h. The resultant lytic 
areas were then observed. Photography of the fibrin plates was performed 
with indirect illumination on a black background. Molecular mass markers 
allowed for calculation of relative molecular masses. 
Fibrinolytic  Activity Localization by Fibrin Overlay 
Localization of fibrinolytic activity in 8-I.tm cryostat sections of mouse ster- 
nomastoid sections was performed as previously described (30, 53). Briefly, 
both end plate and non-end plate regions of muscle were frozen in isopen- 
line pre-cooled in liquid N~ and kept at  -80°C until sectioned. Cryostat 
sections were briefly air dried and then a mixture of  60 ~tl plasminogen-free 
human fibrinogen (1%) and 10 Ixl of bovine thrombin (20 NIH U/ml) at 4°C 
was added and quickly spread thin. The thin clot was then allowed to be- 
come stabilized at 22°C for 20 rain before incubation of sections in a moist 
chamber at 37°C for varying times. To determine if plasminogen-depen- 
dence of muscle section fibrinolysis was present, 80 Ixg/ml (20-50 I~1) of 
purified human glu-plasminogen was added,  After incubation,  sections 
were fixed in  10%  formaldehyde, washed, and then stained with Harris' 
hematoxylin. 
Protein determination was estimated by the method of Bradford (3) using 
Coomassie Brilliant Blue-G (Sigma Chemical Co.) as the color indicator. 
All other chemicals were of reagent grade.  Statistical analysis was per- 
formed using the two-tailed Student's t test. 
Results 
Atrophy and Protein Measurements 
Table  I  shows  the  expected  decrease  in  bulk  of  sciatic- 
innervated leg muscles after denervation (27, 59). The earli- 
est atrophy was not detected until 4  d and the greatest de- 
crease occurred between 4 and 7 d (10-27 % reduction). The 
rate of muscle atrophy plateaued after 10 d, with little differ- 
ence between 10 and 17 d.  In addition to bulk atrophy, de- 
crease in noncollagenous protein was also found, as has been 
demonstrated previously  (27,  59). 
PA Amidolytic Activity 
Using a sensitive amidolytic assay with a synthetic peptidyl 
chromogenic  substrate  (S-2251)  specific  for plasmin  (49), 
activity under our assay conditions was entirely dependent 
upon  the  addition  of highly purified  human plasminogen 
(Fig.  1). Plasminogen-independent activity was barely above 
the zero value even after 6 h incubation. This was true even 
for control muscle but was strikingly seen in the denervated 
muscle samples.  Using the 125I-fibrin plate assay (56), pre- 
vious studies with neutral protease enzymes secreted from 
clonal mouse muscle  (18) and rat muscle  in organ culture 
(Festoff, B. W., unpublished results) had indicated consider- 
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Days after  No  Wet weight 
denervation  animals  per animal  Decrease  Protein$  Decrease 
g  %  mg/g  % 
2  13  Control  0.30  13.0 
Denervated  0.29  3  12.8  2 
4  5  Control  0.30  12.5 
Denervated  0.27  10  11.8  6 
7  20  Control  0.33  14.2 
Denervated  0.24  27  11.4  20 
10  22  Control  0.35  13.0 
Denervated  0.22  37  8.0  38 
17  6  Control  0.33  13.1 
Denervated  0.19  42  7.5  45 
* Values are averages of three experiments and were within 5-8%. 
$ Noncollagenous proteins, determined as described in Materials and Methods. 
able PA activity but plasminogen-independent activity, espe- 
cially in muscle homogenates, was also detected. Moreover, 
in the current series of experiments, the addition of FM (49) 
was used to distinguish fibrin-dependent (i.e., tPA) and fi- 
brin-independent (i.e., uPA) PA activities in muscle extracts. 
Confirmation that amidolysis of S-2251 was dependent on 
the presence of lys-plasminogen is further demonstrated in 
Fig. 2 where the plasminogen concentration is varied. Ami- 
dolysis increased with the plasminogen concentration in a 
linear fashion and plateaued above 40 lxg/ml, consistent with 
other reports (49). Amidolysis was also critically dependent 
on the pH of the medium with maximum activity at pH 7.6, 
and was completely inhibited by aprotinin at 5 KIU/ml (not 
shown). This study indicated that amidolytic activity in mus- 
cle extracts represented only PA. 
Effects of  Denervation on Muscle 
Plasminogen-dependent Amidolytic Activity 
The effect of mid-sciatic neurectomy on muscle PA activity 
at different times after nerve section is shown in Fig. 3. The 
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Figure 1. Effects of plasminogen on amidolytic activity of control 
and denervated  muscle  extracts.  Little  or no amidolytic  activity 
using S-2251 (see Materials and Methods) is found for control or 
10-d denervated muscle in absence of plasminogen. 
PA activity measured in the presence of FM increased almost 
10-fold by 7 d after neurectomy. The most rapid increase in 
PA activity occurred between 2 and 4 d. After this time, PA 
activity, determined in the presence of FM, appeared to pla- 
teau. PA activity in the absence of FM rose more gradually 
but also plateaued during the course of this temporal study 
of denervation. As shown, little or no change occurred in the 
contralateral,  unoperated leg muscle activity, either in the 
absence or presence of FM. 
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Figure 2. Concentration dependency of muscle amidolytic activity 
on lys-plasminogen. Purified human lys-plasminogen (see Materi- 
als and Methods) was added, in increasing concentration, to dener- 
vated muscle extracts, and activity after a 4-h incubation was com- 
pared. The linear portion of  the curve, 10-40 Ixg/ml,  correlates with 
that of PA enzymatic activity. 
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Figure 3.  Time  course  of PA  activity  after denervation.  Fibrin 
monomer-dependent PA activity was assayed for control (e) and 
denervated  (o) muscle extracts as well as fibrin-independent  PA 
activity  in control  (-) and denervated  ([]) extracts  according  to 
techniques described  in Materials  and Methods. 
l~brin Zymography of  Muscle Extracts 
We used fibrin zymography to more specifically identify the 
type of PA that increased in denervated muscle. Fig. 4 shows 
a typical fibrin zymogram of control and denervated muscle 
extracts,  obtained at varying times after denervation.  This 
technique enabled us to extend our biochemical results and 
offered the possibility to detect the presence of PA-inhibitor 
complexes (37, 55).  The dark field photograph of a  fibrin 
zymogram shows control and denervated (at three different 
times) muscle extract along with purified human tPA  (lane 
1)  and uPA  (lane 2),  the latter showing the high and low 
molecular mass human uPAs. Clear lysis zones at 48 kD are 
seen with mouse muscle extracts from all times of denerva- 
tion (lanes 4, 6, and 8). In contrast, lysis zones were not ob- 
served with control muscle extracts (lanes 3,  5,  and  7),  at 
equivalent  protein  loads.  Lysis  was  also  not  seen  when 
threefold-overloaded  control  samples  were  added  (not 
shown). 
The major band of fibrinolytic activity at 48 kD migrates 
just between the positions of high (55 kD), and low (33 kD) 
molecular mass human uPA. A smaller band, evident in the 
later  denervation  extracts  (lanes  6  and  8),  at  75  kD,  co- 
migrates with pure human tPA.  In neither the control nor 
denervated muscle extracts could a  high molecular weight 
lytic zone, comparable to activity arising from a complex of 
tPA and tPA inhibitor at 100 kD (37) or uPA and uPA inhibitor 
at 68  kD (9) be detected. 
Cellular Localization of  Muscle Tissue PA 
To attempt to localize the PA activity in control and dener- 
vated muscle, we used the fibrin overlay technique (30,  53). 
This  technique  has  previously been used  to  detect  PA  in 
sciatic nerve and spinal cord from several species (53)  as 
well as in a number of vascular tissues (30). In mouse mus- 
cle, we found a relative dependence of fibrinolysis on plas- 
minogen on cryostat sections.  When overlays of plasmino- 
gen-free human fibrogen were used, incubation for at least 
3 h at 37°C was required to demonstrate lytic zones for both 
Figure 4. Fibrin zymogram of control and denervated muscle extracts.  Electrophoresis  of extracts from control (lanes 3, 5, and  7) and 
denervated (lanes 4, 6, and 8) muscle at 7 (lanes 3 and 4),  10 (lanes 5 and 6) and 17 (lanes 7and 8) d after denervation applied to fibrin 
layer as described  in Materials  and Methods.  (Lane 1) Human tPA obtained from recombinant  DNA techniques;  (lane 2) human uPA 
(purified from urine). 
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lying blood vessels (not shown). In contrast, when purified 
human plasminogen was added, after only 30 min, large lyric 
zones were present over denervated muscle fibers, in areas 
that also included muscle fascicles and interfascicular blood 
vessels (Fig. 5, a and b). Reproducibly, lysis was found over 
denervated fibers where no vessels were present (5 b, lower 
right)  as  well  as  when  vessels  were underlying  the  lyric 
zones. However, lysis occurred only over blood vessels after 
3 h in control muscle cryostat sections, even in the presence 
of plasminogen (Fig. 5, c and d). In a number of sections of 
denervated muscle, lysis was also detected over the connec- 
tive tissue  and  at the  transition  zone between  denervated 
fibers and the interfascicular matrix (not shown). 
Discussion 
Our present results indicate that adult, innervated mammal- 
ian skeletal muscle contains detectable amounts of plasmino- 
gen-dependent  amidolytic  activity  (Figs.  1  and  2).  After 
sciatic  neurectomy,  with  removal  of a  5-mm  segment  of 
nerve, PA activity rises dramatically in the muscle, in ad- 
vance of the  expected decrease  in  muscle bulk  (Table I). 
Lysosomal and cathepsin-like enzymes were not measured 
in these studies, since little or no amidolyric activity could 
be detected in the absence of plasminogen in the incubation 
mixture. However, other reports have indicated that signifi- 
cant  increases of these plasminogen-independent enzymes 
occur somewhat later than the presently reported rise in PA 
(41,  45, 46).  The rime course of amidolyric activity shows 
more than twice the PA activity in control muscle as early 
as  2  d  after  neurectomy  (the  earliest time point  in  these 
studies) in denervated muscle which progressively increases 
until day 7 and plateaus afterwards. The dependence of PA 
activity on fibrin was also studied.  In the absence of FM, 
there was a consistent increase in PA activity after denerva- 
tion indicating an increase in fibrin-independent PA activity. 
In the presence of FM, the steady increase in PA activity was 
higher than that observed in the absence of FM, indicating 
an additional  increase in fibrin-dependent PA activity.  Be- 
cause fibrin is required for tPA-induced plasminogen activa- 
tion (i.e.; tPA), these results were compared with those ob- 
tained by the fibrin zymography by evaluating the intensity 
of the  fibrin lysis area as well as the Mr of the  activator. 
Using this technique, the presence and increase in the 48-kD 
lyric band occurred first after nerve section (Fig. 4, lanes 4, 
Figure 5. Fibrin overlay to localize PA activity in muscle. Frozen sections (8 p.m) of control (c and d) or denervated (a and b) were overlaid 
with plasminogen-free fibrinogen. The formation of fibrin was generated by adding bovine thrombin,  and incubating for 30 min (a and 
b) or 3 h (c and d) at 37°C as described in Materials and Methods. In a and c, the plane of focus is on the fibrin layer showing the fibrils, 
while in b and d, the focus is on the underlying muscle.  In b, two areas of fibrinolysis are shown-a larger one with atrophied muscle 
fibers, blood vessels, and mononuclear  cells;  and a smaller zone where only dr~ervated  fibers are found (lower right) underlying lytic 
zone. Bar,  100 Ixm. 
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at a later time after denervation. The Mr of the PA detected 
earliest in denervated muscle (seen even at 2 d) correlates 
well with uPA from mouse sarcoma (7), antibodies to which 
identify this enzyme in a variety of mouse tissues (35). In 
addition, the 75-kD PA detected in denervated muscle after 
10 d also correlates well for both human (9) (Fig. 4, lane 1 ) 
and mouse (8) tPA. In both human and mouse, anti-tPA anti- 
bodies fail to recognize uPA (9). 
From  our  present  data  we  conclude  that  denervation 
results initially in an increase in uPA with subsequent eleva- 
tion of tPA.  We have arrived at this conclusion despite the 
results shown in Fig. 3, where early after denervation, plas- 
minogen-dependent amidolytic activity is greatest when ex- 
ogenous FM is added. Precise determination of tPA and uPA 
based only on the difference in amidolytic activity with or 
without added FM is difficult in this system. As a matter of 
fact, in contrast to other systems, such as conditioned media 
or extracts from cultured cells, these muscle extracts consist 
of a markedly heterogeneous mixture of components. Such 
as yet unidentified components might be able to activate the 
PA enzymes or pro-enzymes after tissue disruption.  Some 
may be able to potentiate activity before the addition of exog- 
enous potentiator (in these assays, the FM). In fact, recent 
evidence (19) suggests that in the absence of fibrin, the PA 
activity of denervated muscle  depends  upon  the  dilution 
used, thus implying the presence of a PA potentiator. The 
augmentation of PA activity might depend upon the presence 
of known or unknown potentiator(s) of PA.  Fibrin or even 
fibronectin degradation products (58) might be candidates 
for this role. Consequently, the fibrin zymograms provide us 
with direct evidence that uPA-like activity predominates and 
is first activated after denervation. This point is important in 
dealing with a potential question as to where in the muscle 
this activity originates. It is known that denervated muscle, 
in particular slow-twitch muscle,  becomes hypervascular- 
ized after denervation (27). However, increase in blood sup- 
ply occurs considerably later after denervation than the times 
used for the present study.  The observation that ltPA, acti- 
vated as early as 2 d after denervation (Fig. 4 and not shown), 
precedes the tPA activation suggests that this PA does not 
arise from the plasma. In plasma, uPA is present as an inac- 
tive  pro-enzyme whereas  tPA,  secreted  by  vascular  en- 
dothelial cells, is active (9, 37). 
We  were  unsuccessful  in  detecting  significant  ¢t2-anti- 
plasmin or "fast-acting inhibitor" (55) activity in muscle ex- 
tracts. However, mouse muscle inhibitor(s) did effect human 
tPA resulting in 50% inhibition compared to buffer controls 
(19).  Cellular PA inhibitors,  such as protease nexin (2,  11, 
36), may be important in containing this type of PA in mus- 
cle, even more so than the plasma inhibitors. We have previ- 
ously identified a protease nexin in cultured mouse muscle 
cells, where it appears to be developmentally regulated (17). 
The function of increased uPA in denervated muscle may 
be similar to its proposed role in tissue degradation in cancer 
(9). The rationale for such degradation in muscle might be 
to remove certain basement membrane components of the 
muscle fiber to allow for orderly reinnervation. In this re- 
gard, muscle fiber basement membrane-associated fibronec- 
tin and type IV collagen are exquisitely sensitive to the uPA 
in denervated muscle (28). These findings are qualitatively 
similar to those reported by Gulati et al.  (23-26) in auto- 
transplanted muscle where these same components of the 
basement membrane zone first disappear and are then re- 
synthesized during muscle regeneration. However, they differ 
considerably for the findings in allo-transplants where the 
muscle graft is rejected and basement membrane zone com- 
ponents are not degraded, but persist (23). 
The role of the nerve in controlling muscle PA is likely not 
to be passive. It may function to regulate PA synthesis, at ei- 
ther transcriptional or translational levels, and/or may also 
function posttranslationally, to inactivate the PA after it is 
released. A similar model was previously proposed to be the 
mechanism for the normal turnover of basement membrane 
components, augmentation of  which might occur experimen- 
tally,  or in the fatal human neuromuscular disorder, amyo- 
trophic lateral sclerosis (15). In this regard, it has recently 
been shown that nerves also secrete PAs (31, 47, 57) and that 
concentration of PA is found at axon growth cones (32, 33). 
Study of  the PA-plasmin system, its inhibitors (2, 11, 22, 36), 
and other factors involved in both thrombosis and fibrinoly- 
sis in the peripheral and central nervous systems may help 
to elucidate some of the questions raised by the current study. 
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